Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Kowa Pharmaceuticals America, Inc. 401(K) Plan is a benefit plan reported by Kowa Pharmaceuticals America, Inc. under EIN 20-1414357 and plan number 001. The latest loaded filing year is 2023. The filing reports 518 participants and $35,587,390 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $35,587,390
- Net assets (EOY)
- $35,587,390
- Net assets (BOY)
- $31,993,073
Income & contributions
- Employer contributions
- $878,207
- Participant contributions
- $2,674,643
- Total contributions
- $3,771,175
- Total income / additions
- $8,631,345
Expenses & distributions
- Benefits paid
- $5,022,698
- Administrative expenses
- $14,330
- Total expenses
- $5,037,028
- Net increase / (decrease)
- $3,594,317